Index DJIA, S&P 500
P/E 141.95
EPS (ttm) 0.90
Insider Own 0.15%
Shs Outstand 2.53B
Perf Week -2.81%
Market Cap 322.94B
Forward P/E 12.92
EPS next Y 9.87
Insider Trans -10.71%
Shs Float 2.53B
Perf Month -0.12%
Income 2.31B
PEG 2.13
EPS next Q 2.13
Inst Own 78.61%
Short Float 0.81%
Perf Quarter 0.87%
Sales 61.09B
P/S 5.29
EPS this Y 471.17%
Inst Trans 0.64%
Short Ratio 2.49
Perf Half Y 23.98%
Book/sh 15.94
P/B 8.00
EPS next Y 14.43%
ROA 2.16%
Short Interest 20.43M
Perf Year 7.86%
Cash/sh 2.25
P/C 56.55
EPS next 5Y 66.74%
ROE 5.29%
52W Range 99.14 - 133.10
Perf YTD 16.96%
Dividend Est. 3.23 (2.53%)
P/FCF 29.25
EPS past 5Y -42.70%
ROI 3.22%
52W High -4.20%
Beta 0.42
Dividend TTM 3.00 (2.35%)
Quick Ratio 0.99
Sales past 5Y 7.72%
Gross Margin 71.63%
52W Low 28.62%
ATR (14) 2.11
Dividend Ex-Date Mar 14, 2024
Current Ratio 1.25
EPS Y/Y TTM -97.48%
Oper. Margin 9.16%
RSI (14) 50.30
Volatility 1.55% 1.48%
Employees 72000
Debt/Eq 0.85
Sales Y/Y TTM 7.01%
Profit Margin 3.77%
Recom 1.52
Target Price 142.30
Option/Short Yes / Yes
LT Debt/Eq 0.77
EPS Q/Q 69.28%
Payout 2065.60%
Rel Volume 0.76
Prev Close 128.26
Sales Surprise 3.75%
EPS Surprise 9.79%
Sales Q/Q 8.38%
Earnings Apr 25 BMO
Avg Volume 8.21M
Price 127.51
SMA20 0.14%
SMA50 0.85%
SMA200 12.27%
Trades
Volume 6,221,846
Change -0.58%
Date
Action
Analyst
Rating Change
Price Target Change
Mar-11-24 Downgrade
Societe Generale
Hold → Sell
$104
Jan-04-24 Upgrade
TD Cowen
Market Perform → Outperform
$125 → $135
Nov-09-23 Initiated
Deutsche Bank
Buy
$115
Oct-27-23 Upgrade
BMO Capital Markets
Market Perform → Outperform
$132
Oct-20-23 Upgrade
UBS
Neutral → Buy
$117 → $122
Jul-14-23 Initiated
HSBC Securities
Hold
$123
Apr-13-23 Upgrade
Citigroup
Neutral → Buy
$105 → $130
Mar-28-23 Downgrade
Societe Generale
Buy → Hold
Mar-13-23 Downgrade
Wells Fargo
Overweight → Equal Weight
$120 → $115
Mar-06-23 Initiated
Jefferies
Buy
$125
Feb-22-23 Upgrade
Wolfe Research
Peer Perform → Outperform
$127
Jan-04-23 Upgrade
BofA Securities
Neutral → Buy
$110 → $130
Nov-18-22 Initiated
Credit Suisse
Outperform
$120
Oct-10-22 Upgrade
Guggenheim
Neutral → Buy
Sep-14-22 Upgrade
Berenberg
Hold → Buy
$95 → $100
Jul-06-22 Upgrade
Daiwa Securities
Neutral → Buy
$89 → $102
Jun-06-22 Resumed
SVB Leerink
Outperform
$102
Apr-06-22 Resumed
Morgan Stanley
Equal-Weight
$80
Dec-17-21 Initiated
Goldman
Buy
$93
Dec-16-21 Initiated
Daiwa Securities
Neutral
$70
Show Previous Ratings
May-03-24 09:50AM
May-02-24 02:53PM
May-01-24 06:52PM
07:15AM
Apr-30-24 08:44AM
09:00AM
Loading…
Apr-29-24 09:00AM
Apr-28-24 06:54PM
Apr-27-24 09:14AM
Apr-26-24 10:59AM
Apr-25-24 05:54PM
04:09PM
03:30PM
02:29PM
12:52PM
12:09PM
11:42AM
Loading…
11:42AM
(The Wall Street Journal)
11:34AM
11:23AM
10:54AM
10:30AM
09:13AM
(The Wall Street Journal)
09:13AM
(The Wall Street Journal)
07:30AM
07:04AM
06:44AM
(Associated Press Finance)
06:33AM
06:30AM
06:30AM
Apr-24-24 05:50PM
Apr-23-24 07:49AM
02:39PM
Loading…
Apr-22-24 02:39PM
11:10AM
09:15AM
Apr-21-24 10:49AM
Apr-19-24 07:04AM
Apr-18-24 04:27PM
10:01AM
Apr-17-24 05:50PM
08:00AM
Apr-16-24 03:17PM
Apr-15-24 07:48AM
Apr-12-24 06:40AM
Apr-11-24 05:50PM
Apr-08-24 11:38PM
02:00PM
Apr-07-24 02:00PM
Apr-06-24 08:47PM
Apr-05-24 05:45PM
05:33AM
Apr-04-24 07:38AM
06:45AM
05:36AM
Apr-03-24 05:50PM
08:00AM
Apr-01-24 09:50AM
06:45AM
Mar-29-24 10:51AM
Mar-28-24 05:50PM
09:15AM
06:45AM
Mar-27-24 04:36PM
04:00PM
02:58PM
12:20PM
11:54AM
10:58AM
10:26AM
(The Wall Street Journal)
10:10AM
09:53AM
09:00AM
08:50AM
08:39AM
07:36AM
07:36AM
Mar-26-24 06:21PM
05:07PM
(The Wall Street Journal)
01:12PM
09:30AM
05:15AM
Mar-24-24 09:54AM
Mar-22-24 05:45PM
10:26AM
Mar-21-24 03:00PM
(The Wall Street Journal)
10:25AM
06:45AM
Mar-20-24 05:50PM
Mar-19-24 09:00AM
Mar-15-24 04:23PM
12:17PM
06:45AM
Mar-14-24 07:01PM
05:45PM
Mar-13-24 05:50PM
09:03AM
09:00AM
07:01AM
03:00AM
02:45AM
Mar-11-24 04:53PM
08:15AM
Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock, and companion animal species. The Other segment consists of sales for the non-reportable segments of healthcare services. The company was founded in 1891 and is headquartered in Rahway, NJ.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Romanelli Joseph President, Human Health Int?l May 02 '24 Option Exercise 128.80 2,262 291,346 21,831 May 02 04:29 PM Smart Dalton SVP Fin. - Global Controller May 02 '24 Option Exercise 128.80 381 49,073 3,048 May 02 04:23 PM Merck & Co., Inc. 10% Owner Mar 11 '24 Buy 23.00 21,397,205 492,135,715 1,000 Mar 11 03:27 PM Davis Robert M Chairman, CEO & President Feb 14 '24 Option Exercise 73.73 85,021 6,268,598 433,348 Feb 15 04:01 PM Litchfield Caroline EVP & CFO Feb 14 '24 Option Exercise 58.08 38,291 2,223,941 89,199 Feb 15 04:03 PM Davis Robert M Chairman, CEO & President Feb 14 '24 Sale 125.40 85,021 10,661,574 348,327 Feb 15 04:01 PM Litchfield Caroline EVP & CFO Feb 14 '24 Sale 125.50 38,291 4,805,520 50,908 Feb 15 04:03 PM Davis Robert M Chairman, CEO & President Feb 13 '24 Option Exercise 74.18 150,000 11,127,160 498,327 Feb 15 04:01 PM Davis Robert M Chairman, CEO & President Feb 13 '24 Sale 125.85 150,000 18,877,424 348,327 Feb 15 04:01 PM Romanelli Joseph President, Human Health Int?l Feb 13 '24 Sale 124.89 1,000 124,888 19,569 Feb 14 04:03 PM Li Dean Y Executive VP & President, MRL Feb 09 '24 Option Exercise 62.07 14,702 912,553 60,944 Feb 12 04:03 PM Li Dean Y Executive VP & President, MRL Feb 09 '24 Sale 125.50 14,702 1,845,083 46,242 Feb 12 04:03 PM Williams David Michael EVP,Chief Info&Digital Officer Feb 07 '24 Sale 127.57 1,451 185,108 19,812 Feb 08 04:04 PM MIZELL STEVEN EVP, Chief HR Officer Feb 02 '24 Option Exercise 73.65 32,994 2,430,159 74,313 Feb 02 04:07 PM Zachary Jennifer EVP, General Counsel Feb 02 '24 Option Exercise 87.10 19,417 1,691,221 78,557 Feb 02 04:05 PM Oosthuizen Johannes Jacobus President, U.S. Market Feb 02 '24 Option Exercise 78.80 20,937 1,649,906 42,286 Feb 05 04:01 PM MIZELL STEVEN EVP, Chief HR Officer Feb 02 '24 Sale 126.65 50,694 6,420,349 23,619 Feb 02 04:07 PM Zachary Jennifer EVP, General Counsel Feb 02 '24 Sale 126.97 49,499 6,284,779 29,058 Feb 02 04:05 PM Oosthuizen Johannes Jacobus President, U.S. Market Feb 02 '24 Sale 127.17 18,959 2,411,111 23,327 Feb 05 04:01 PM Oosthuizen Johannes Jacobus President, U.S. Market Nov 09 '23 Sale 102.38 2,081 213,061 18,191 Nov 13 07:36 AM DeLuca Richard R. EVP&Pres, Merck Animal Heallth Nov 08 '23 Sale 105.03 43,823 4,602,668 111,764 Nov 09 09:04 AM Oosthuizen Johannes Jacobus President, U.S. Market Oct 30 '23 Option Exercise 102.82 915 94,080 20,723 Oct 31 11:08 AM MIZELL STEVEN EVP, Chief HR Officer Aug 14 '23 Sale 109.01 4,250 463,292 22,935 Aug 15 04:08 PM Guindo Chirfi Chief Marketing Officer Aug 03 '23 Option Exercise 105.70 36,901 3,900,436 38,342 Aug 04 04:17 PM MIZELL STEVEN EVP, Chief HR Officer Aug 03 '23 Sale 105.49 4,500 474,701 27,185 Aug 04 04:06 PM Romanelli Joseph President, Human Health Int?l Aug 02 '23 Sale 107.37 59 6,335 0 Aug 03 04:08 PM Romanelli Joseph President, Human Health Int?l Aug 02 '23 Sale 107.37 30 3,221 20,569 Aug 03 04:08 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite